Metastatic Prostate Cancer Prognosis Calculator
Assess life expectancy and survival probability for prostate cancer patients
Calculate Prostate Cancer Prognosis
Demographics
Age in years
Medical Information
Score from prostate biopsy (lower is better)
Cancer spread outside prostate and seminal vesicles
Compared to peers of the same age
Smoking increases cancer mortality risk
Prostate Cancer Stages
T1 (Stage I)
Cannot be felt/seen, ~99% survival
T2 (Stage II)
Within prostate, ~96% survival
T3 (Stage III)
Outside prostate, ~91% survival
T4 (Stage IV)
Spread to organs/nodes, ~31% if metastatic
Gleason Score Guide
Higher scores indicate more aggressive cancer
Key Risk Factors
Understanding Prostate Cancer Prognosis
What affects prognosis?
Prostate cancer prognosis depends on multiple factors including stage at diagnosis, Gleason score, patient age, overall health, and presence of metastases. Early-stage prostate cancer has excellent survival rates, with over 98% of patients surviving 10+ years.
Survival Statistics
- •5-year survival: Nearly 100% overall
- •10-year survival: Nearly 98% overall
- •15-year survival: Nearly 95% overall
- •Metastatic disease: 31% 5-year survival
Calculation Methodology
This calculator uses validated research data from multiple studies (Zhang et al., 2015; Huncharek et al., 2010; Albertsen et al., 2005) combined with Social Security Actuarial Life Tables to estimate prognosis.
Key Factors
Gleason Score Impact
Higher scores correlate with increased mortality risk, ranging from 6x (score 2-4) to 121x (score 8-10) baseline risk.
BMI and Lifestyle
Obesity (BMI ≥30) increases mortality risk by 24%, while smoking increases risk by 14%.
Early Stage Treatment
- • Active surveillance
- • Radical prostatectomy
- • Radiation therapy
- • Excellent outcomes
Advanced Disease
- • Hormone therapy
- • Chemotherapy
- • Targeted therapy
- • Immunotherapy
Supportive Care
- • Pain management
- • Nutritional support
- • Psychological support
- • Quality of life focus
⚠️ Important Medical Disclaimer
This calculator provides estimates only and cannot predict individual outcomes.
- • All calculations are based on population statistics and research data
- • Individual prognosis varies significantly based on many factors
- • Treatment advances continue to improve outcomes
- • Early detection and proper treatment are crucial
- • Always consult with qualified oncologists and urologists
- • This tool should never replace professional medical advice